2000 Year End Review - Industry Report: Biotechnology
Charts: [
Total Amount Raised |
Average Amount Raised |
Number of Offerings
]
|
|
| Report Type: | Offer to Most Recent Quote |
| Period: | 01/2000 - 12/2000 |
| Sort Criteria: | Percentage Change |
| Industry: | Biotechnology |
| Securities Types: | Common Stock, ADS |
| Underwriting Types: | Firm Committment |
| Region(s): | all regions |
| Foreign Companies: | included |
|
|
|
|
| Number of IPOs: | 63 |
| Largest Company: | Tanox, Inc. |
| Smallest Company: | ISTA Pharmaceuticals, Inc. |
| Best Performer: | First Horizon Pharmaceutical Corp. (+284.7%) |
| Worst Performer: | Curon Medical, Inc. (-63.9%) |
| Total Amount Raised: | $5032.5 Mil. |
| Average Amount Raised: | $79.9 Mil. |
| Average Percentage Change: | +9.89 % |
|
|
| Company |
Symbol |
Offer Date |
Offer Price |
Close Price on 12/29/00 |
Percent Change |
Market Value ($Mil) |
| First Horizon Pharmaceutical Corp. |
FHRX |
5/31 |
$8.00 |
$30.750 |
+284.7% |
$379.4 |
|
| PRAECIS Pharmaceuticals, Inc. |
PRCS |
4/27 |
$10.00 |
$29.250 |
+192.% |
$1169.0 |
|
| InterMune Pharmaceuticals, Inc. |
ITMN |
3/24 |
$20.00 |
$44.625 |
+123.2% |
$901.1 |
|
| Inspire Pharmaceuticals, Inc. |
ISPH |
8/3 |
$12.00 |
$26.063 |
+117.9% |
$639.2 |
|
| EDEN Bioscience Corporation |
EDEN |
9/27 |
$15.00 |
$29.938 |
+99.8% |
$680.6 |
|
| Orchid BioSciences, Inc. |
ORCH |
5/5 |
$8.00 |
$14.000 |
+75.0% |
$448.0 |
|
| Charles River Laboratories Corp. |
CRL |
6/23 |
$16.00 |
$27.375 |
+71.9% |
$884.8 |
|
| Luminex Corp. |
LMNX |
3/30 |
$17.00 |
$26.063 |
+53.1% |
$695.3 |
|
| Dendreon Corp. |
DNDN |
6/16 |
$10.00 |
$15.000 |
+50.0% |
$311.3 |
|
| Adolor Corp. |
ADLR |
11/14 |
$15.00 |
$22.000 |
+46.6% |
$590.7 |
|
| Paradigm Genetics, Inc. |
PDGM |
5/5 |
$7.00 |
$10.000 |
+42.5% |
$239.1 |
|
| Rigel Pharmaceuticals, Inc. |
RIGL |
11/29 |
$7.00 |
$10.000 |
+42.5% |
$358.5 |
|
| Dyax Corp. |
DYAX |
8/15 |
$15.00 |
$21.203 |
+41.5% |
$383.8 |
|
| Cepheid |
CPHD |
6/21 |
$6.00 |
$8.438 |
+40.3% |
$215.3 |
|
| Genaissance Pharmaceuticals, Inc. |
GNSC |
8/2 |
$13.00 |
$18.000 |
+38.6% |
$388.5 |
|
| Tanox, Inc. |
TNOX |
4/7 |
$28.50 |
$39.188 |
+37.0% |
$1605.7 |
|
| ViroLogic, Inc. |
VLGC |
5/2 |
$7.00 |
$9.125 |
+30.5% |
$179.6 |
|
| Sangamo BioSciences, Inc. |
SGMO |
4/6 |
$15.00 |
$19.500 |
+30.0% |
$406.7 |
|
| The Medicines Company |
MDCO |
8/8 |
$16.00 |
$20.500 |
+28.2% |
$579.3 |
|
| Pain Therapeutics, Inc. |
PTIE |
7/14 |
$12.00 |
$14.875 |
+23.5% |
$384.2 |
|
| Harvard Bioscience, Inc. |
HBIO |
12/7 |
$8.00 |
$9.875 |
+23.3% |
$244.7 |
|
| POZEN, Inc. |
POZN |
10/11 |
$15.00 |
$18.250 |
+21.6% |
$482.3 |
|
| Esperion Therapeutics, Inc. |
ESPR |
8/10 |
$9.00 |
$10.875 |
+20.3% |
$261.3 |
|
| Array Biopharma, Inc. |
ARRY |
11/17 |
$7.50 |
$8.938 |
+19.7% |
$191.3 |
|
| Rosetta Inpharmatics, Inc. |
RSTA |
8/3 |
$14.00 |
$16.000 |
+14.8% |
$479.1 |
|
| Exelixis, Inc. |
EXEL |
4/11 |
$13.00 |
$14.625 |
+12.% |
$625.4 |
|
| ISTA Pharmaceuticals, Inc. |
ISTA |
8/22 |
$10.50 |
$11.250 |
+7.4% |
$10.4 |
|
| Regeneration Technologies, Inc. |
RTIX |
8/10 |
$14.00 |
$14.250 |
+1.8% |
$303.6 |
|
| Keryx Biopharmaceuticals, Inc. |
KERX |
7/28 |
$10.00 |
$10.125 |
+1.5% |
$190.6 |
|
| Illumina, Inc. |
ILMN |
7/28 |
$16.00 |
$16.063 |
+0.9% |
$506.0 |
|
| DURECT Corp. |
DRRX |
9/28 |
$12.00 |
$12.000 |
+0.0% |
$549.7 |
|
| Genencor International, Inc. |
GCOR |
7/28 |
$18.00 |
$18.000 |
+0.0% |
$1059.6 |
|
| GenVec, Inc. |
GNVC |
12/12 |
$9.50 |
$9.500 |
+0.0% |
$169.3 |
|
| 3-Dimensional Pharmaceuticals, Inc. |
DDDP |
8/4 |
$15.00 |
$14.813 |
-1.4% |
$285.0 |
|
| Genomic Solutions, Inc. |
GNSL |
5/5 |
$8.00 |
$7.625 |
-4.8% |
$173.2 |
|
| Telik, Inc. |
TELK |
8/11 |
$7.00 |
$6.625 |
-5.5% |
$139.6 |
|
| Applied Molecular Evolution, Inc. |
AMEV |
7/27 |
$19.00 |
$17.063 |
-10.9% |
$361.8 |
|
| Arena Pharmaceuticals, Inc. |
ARNA |
7/28 |
$18.00 |
$15.500 |
-13.8% |
$325.4 |
|
| Variagenics, Inc. |
VGNX |
7/21 |
$14.00 |
$11.859 |
-15.9% |
$264.5 |
|
| Ciphergen Biosystems, Inc. |
CIPH |
9/29 |
$16.00 |
$13.250 |
-17.8% |
$339.6 |
|
| Versicor, Inc. |
VERS |
8/3 |
$11.00 |
$8.625 |
-21.9% |
$190.1 |
|
| Lexicon Genetics Inc |
LEXG |
4/7 |
$22.00 |
$16.625 |
-24.3% |
$789.9 |
|
| Kosan Biosciences, Inc. |
KOSN |
10/5 |
$14.00 |
$10.500 |
-25.0% |
$250.4 |
|
| Diversa Corp |
DVSA |
2/14 |
$24.00 |
$17.938 |
-25.5% |
$588.6 |
|
| OraPharma Inc |
OPHM |
3/9 |
$18.00 |
$13.250 |
-26.8% |
$166.9 |
|
| Rita Medical Systems, Inc. |
RITA |
7/27 |
$12.00 |
$8.500 |
-29.6% |
$115.1 |
|
| Transgenomic Inc |
TBIO |
7/18 |
$15.00 |
$10.500 |
-30.0% |
$181.9 |
|
| Deltagen, Inc. |
DGEN |
8/3 |
$15.00 |
$10.438 |
-30.1% |
$300.7 |
|
| Discovery Partners International, Inc. |
DPII |
7/27 |
$18.00 |
$12.125 |
-32.3% |
$271.6 |
|
| MediChem Life Sciences, Inc.(MCR Holdings) |
MCLS |
10/26 |
$7.00 |
$4.625 |
-33.2% |
$117.3 |
|
| Intrabiotics Phamaceuticals, Inc. |
IBPI |
3/28 |
$15.00 |
$9.625 |
-35.3% |
$275.1 |
|
| Compugen Ltd. |
CGEN |
8/10 |
$10.00 |
$6.250 |
-37.% |
$157.5 |
|
| AtheroGenics, Inc. |
AGIX |
8/9 |
$8.00 |
$5.000 |
-37.% |
$114.0 |
|
| deCODE Genetics Inc |
DCGN |
7/18 |
$18.00 |
$10.500 |
-41.6% |
$428.8 |
|
| Argonaut Technologies, Inc. |
AGNT |
7/19 |
$15.00 |
$8.500 |
-43.3% |
$139.4 |
|
| Large Scale Biology Corp. |
LSBC |
8/10 |
$17.00 |
$9.500 |
-44.1% |
$212.4 |
|
| SEQUENOM, Inc. |
SQNM |
2/1 |
$26.00 |
$14.000 |
-46.5% |
$315.3 |
|
| Aclara Biosciences, Inc. |
ACLA |
3/21 |
$21.00 |
$10.875 |
-48.1% |
$339.0 |
|
| Pharsight Corp. |
PHST |
8/9 |
$10.00 |
$4.750 |
-52.% |
$87.5 |
|
| Allos Therapeutics, Inc. |
ALTH |
3/28 |
$18.00 |
$8.063 |
-55.0% |
$184.1 |
|
| Crucell N.V. |
CRXL |
10/27 |
$14.89 |
$6.310 |
-57.2% |
$220.2 |
|
| Gemini Genomics, PLC |
GMNI |
7/25 |
$14.00 |
$5.625 |
-59.2% |
$363.9 |
|
| Curon Medical, Inc. |
CURN |
9/22 |
$11.00 |
$4.016 |
-63.9% |
$74.9 |
|
| |
Copyright 1996-2000 IPO Monitor. All rights reserved. Redistribution or publication of this content is
expressly prohibited without the prior written consent of IPO Monitor.
This information is provided AS-IS, without any warranty of any kind.
IPO Monitor makes no claims concerning the accuracy or validity of the
information, and shall not be held liable for any errors, delays,
omissions or use thereof.
Please report problems with this site to:
ipo-admin@ipomonitor.com
|
|